Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Taro pharmaceutical industries ltd org - Caught on Camera

3 A-Rated Pharma Stocks to Buy for Long-Term Growth

With surging medical needs, advances in precision medicine, and the adoption of generative AI, the pharmaceutical industry is thriving. Thus, it could be ideal to invest in quality pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN), and Merck (MRK) for long-term growth. These stocks are rated A (Strong Buy) in our…

StockNews.com

3 A-Rated Pharma Stocks to Boost Your Bottom Line

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

StockNews.com

3 Top-Rated Pharma Stock Picks to Consider in the New Year

The pharmaceutical industry is expected to grow rapidly due to rising global medical needs and technological advancements. With the industry expected to thrive in the coming years, it could be wise to buy Zoetis (ZTS), AstraZeneca (AZN) and Taro Pharmaceutical (TARO) for steady returns. Read more.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyzing December Profit Potential for the Top 4 Pharma Stocks

The global pharmaceutical market is witnessing robust growth, fueled by an escalating demand for healthcare services amid a burgeoning and aging population. Hence, fundamentally solid pharma stocks Novartis (NVS), Bristol-Myers Squibb (BMY), AbbVie (ABBV), and Taro Pharmaceutical (TARO) might be solid buys for gains this month. Read more.

StockNews.com

3 High-Performing Pharma Stocks to Boost Your Portfolio

The growing adoption of innovative drugs is expected to boost the pharmaceutical industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN) and AbbVie (ABBV) to boost your portfolio. Read on….

StockNews.com

3 Pharma Stocks Smart Money Is Following in September

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

StockNews.com

3 Pharma Stocks to Buy for Value Investors

The pharma industry is well-positioned to witness significant growth due to the continuous advancements in artificial intelligence and increasing demand for innovative drugs. Therefore, fundamentally strong pharma stocks Merck & Co. (MRK), Astellas Pharma (ALPMY), and Taro Pharmaceutical (TARO), which seem to be trading at a discount, might be solid…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Buy These 3 Pharma Stocks in July

The pharmaceutical industry looks well-positioned for long term growth due to the globalization of the industry, increasing investments to develop life-saving drugs, rise in chronic diseases, and a rapidly aging population. To that end, it could be wise to buy fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Ironwood Pharmaceuticals (IRWD),…

StockNews.com

3 Momentum Stocks Leveling Up for Profits

Amid rising fear of recession, the market is expected to remain volatile. Therefore, it could be wise for investors to buy quality stocks Taro Pharmaceutical Industries (TARO), Tennant (TNC), and Carrols Restaurant (TAST), which have soared over the past months and are leveling up for profits. Read more.

StockNews.com

5 High Growth Stocks to Buy Amid a Volatile Market

Concerns over aggressive interest rate hikes to fight the multi-decade high inflation and a looming recession have recently kept the stock market under pressure. However, growth stocks Taro Pharmaceutical (TARO), Superior Industries (SUP), Viavi Solutions (VIAV), CEVA (CEVA), and SMART Global Holdings (SGH) are well-positioned to rebound.

StockNews.com

People

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

AZN

104 stories

BristolMyers Squibb Company

Eli Lilly and Company

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.